levofloxacin has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, SE; Choi, HY; Hyun, JH; Jeon, SS; Woo, SH | 1 |
| Chen, SW; Shen, ZJ; Wang, H; Zhao, JP; Zhou, XL | 1 |
2 other study(ies) available for levofloxacin and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
Topics: Adenocarcinoma; Administration, Oral; Administration, Rectal; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacterial Infections; Biomarkers, Tumor; Biopsy, Needle; Bisacodyl; Cefixime; Epididymitis; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Retrospective Studies; Risk Factors; Ultrasonography, Interventional | 2003 |
Life-threatening meningitis resulting from transrectal prostate biopsy.
Topics: Adenocarcinoma; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biopsy; Escherichia coli Infections; Humans; Levofloxacin; Male; Meningitis; Metronidazole; Ofloxacin; Prostatic Neoplasms; Ultrasound, High-Intensity Focused, Transrectal | 2005 |